Clinical Trial: A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07123038) titled 'A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic' on Aug. 07.

Brief Summary: To assess the emergence, type, severity, and potential causality of delayed adverse events following administration of a gene-modified Treg therapeutic.

Study Start Date: July 22

Study Type: OBSERVATIONAL

Condition: Rheumatoid Arthritis (RA) Hidradenitis Suppurativa (HS)

Intervention: OTHER: Long Term Safety Monitoring Procedures

In accordance with the schedule of assessments, participants will complete the long term safety and health questionnaire and will...